Patent ID: 6586592
Filing Date: 2003-07-01
Classification: A61P,C07D

Abstract:
A compound selected from the group consisting of 5-(1,4-diazepan-1-yl)-2-[(3-fluorophenyl) sulfonyl]phenylamine; 5-(1,4-diazepan-1-yl)-N-ethyl-2-[(3-fluorophenyl) sulfonyl]aniline; N-[5-(1,4-diazepan-1-yl)-2-[(3-fluorophenyl)sulfonyl]phenyl]acetamide; N-[5-(1,4-diazepan-1-yl)-2-[phenylsulfonyl]phenyl]acetamide; and pharmaceutically acceptable salts thereof, wherein the compound includes an isotopic label.